Close Menu
iM.NewsiM.News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

    November 20, 2026

    Robert Pattinson and Suki Waterhouse Redefine Hollywood Power Couples

    November 20, 2026

    Reading Linked to 33% Lower Alzheimer’s Risk, Study Finds

    November 20, 2026
    Facebook X (Twitter) Instagram
    iM.NewsiM.News
    Subscribe
    • Home
    • Lifestyle

      Robert Pattinson and Suki Waterhouse Redefine Hollywood Power Couples

      November 20, 2026

      Reading Linked to 33% Lower Alzheimer’s Risk, Study Finds

      November 20, 2026

      Keto Diet Cuts Liver Fat by 67% in Clinical Trial

      November 20, 2026

      Man Turns In Fugitive Father After Learning He Killed a Child

      November 20, 2026

      Pancreatic Cancer Pill Shows Major Tumour Reduction in Trial

      November 20, 2026
    • Relations

      Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

      November 20, 2026

      Xi Jinping’s Restraint: The Power of Not Acting in Shenzhen

      November 20, 2026

      EU and UK to Sign Reset Deal on Trade and Youth Mobility

      November 20, 2026

      UK and EU to Agree Youth Mobility Scheme at Summit

      November 20, 2026

      White House Cyber Director Sean Cairncross Ousted After Tech Outages

      November 20, 2026
    • Technology

      Microsoft Link to Windows Adds Second Screen Feature

      November 20, 2026

      Nothing Sets December 8 Date for AI Hardware Reveal

      November 20, 2026

      iPhone Air 2 Dummy Unit Reveals Dual-Camera Upgrade

      November 20, 2026

      OpenAI AI Boosts AMD GPU Design by 14 Percent

      November 20, 2026

      Motorola Clarifies Android 17 Rollout for 29 Devices

      November 20, 2026
    • Travel & Tourism

      Oil Spills Threaten UAE and Oman Beaches Amid Hormuz Conflict

      November 20, 2026

      Aer Lingus to Retrofit A330 Fleet with Premium Economy and New Business Class

      November 20, 2026

      Sabre Targets AI Travel Bookings With New Connector

      November 20, 2026

      Riyadh Hotel Revenue Plummets 65% After Airport Attack

      November 20, 2026

      JetBlue Adds Grand Cayman and Honduras Routes From Fort Lauderdale

      November 20, 2026
    • Get in Touch
    iM.NewsiM.News
    Home»Lifestyle»Health»Pancreatic Cancer Pill Shows Major Tumour Reduction in Trial
    Health

    Pancreatic Cancer Pill Shows Major Tumour Reduction in Trial

    im.newsBy im.newsNovember 20, 2026No Comments3 Mins Read3 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Close-up of daraxonrasib pancreatic cancer pill on a medical tray
    Photo: Haymanj / Wikimedia Commons, Public domain
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    A new oral medication for pancreatic cancer has demonstrated significant tumour reduction in a clinical trial, prompting experts to describe the results as a major medical advancement. The drug, known as daraxonrasib, stopped tumour growth in 90% of participants and led to undetectable cancer levels in one in 12 patients.

    Dr Wungki Park, a gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center in New York, presented the findings at the EORTC-NCI-AACR Symposium in Barcelona. He described the results as the closest approach to a cure he has witnessed for advanced disease.

    Daraxonrasib Trial Outcomes

    The trial involved 61 patients who had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body. Participants were treated with the pill for an average of 18 months. During this period, more than 60% of patients experienced tumour shrinkage or disappearance. For approximately 8% of the group, CT scans showed no detectable cancer.

    Memorial Sloan Kettering Rockefeller Outpatient Pavilion
    Photo: Kenneth C. Zirkel / Wikimedia Commons, CC BY 4.0

    Survival rates also improved compared to standard chemotherapy alone. One year after starting treatment, 76.6% of patients were still alive. In contrast, survival rates for patients receiving only chemotherapy typically range between 40% and 45% at the one-year mark.

    Dr Park noted that the duration of disease control appeared to nearly double compared to previous standards. He stated that seeing disease disappear on scans over an average of 18 months was incredible and represented a near-complete remission.

    Memorial Sloan Kettering Cancer Center Main Entrance
    Photo: Kenneth C. Zirkel / Wikimedia Commons, CC BY-SA 4.0

    KRAS Inhibitor Mechanism

    Daraxonrasib functions as a KRAS inhibitor. It works by binding to and shutting off specific genetic mutations found in most pancreatic cancers. These mutations are responsible for driving tumour growth. By targeting this mechanism, the drug aims to halt the progression of the disease.

    Researchers believe this approach could potentially treat dozens of other cancer types. Many other malignancies share similar KRAS gene mutations, suggesting the treatment might have broader applications beyond pancreatic cancer.

    Michelle Mitchell, chief executive of Cancer Research UK, acknowledged the need for further research. She described the results as the biggest leap forward in decades for pancreatic cancer patients. She added that the findings raise the possibility of treating other cancers with Kras gene mutations, though more trials are required before the treatment can be assessed for use on the NHS.

    NABL Accredited Clinical Pathology Laboratory in Kharghar Navi Mumbai Diagnostic Services
    Photo: Goleisureintl / Wikimedia Commons, CC BY 4.0

    Doctors caution that the pill is not yet considered a cure. It is unknown how long the drug can keep the disease at bay or if the remission will be permanent. Longer studies are planned to determine if any cancers can be fully put into remission. Pancreatic cancer remains one of the deadliest forms of the disease, with only about 3% of patients surviving five years after diagnosis when the cancer has spread.

    Source: The Guardian

    cancer research Clinical Trial daraxonrasib Health KRAS inhibitor Oncology pancreatic cancer
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleiPhone Air 2 Dummy Unit Reveals Dual-Camera Upgrade
    Next Article Man Turns In Fugitive Father After Learning He Killed a Child
    im.news

    Related Posts

    Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

    November 20, 2026

    Robert Pattinson and Suki Waterhouse Redefine Hollywood Power Couples

    November 20, 2026

    Reading Linked to 33% Lower Alzheimer’s Risk, Study Finds

    November 20, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

    November 20, 20260 Views

    Robert Pattinson and Suki Waterhouse Redefine Hollywood Power Couples

    November 20, 20261 Views

    Reading Linked to 33% Lower Alzheimer’s Risk, Study Finds

    November 20, 20263 Views

    Microsoft Link to Windows Adds Second Screen Feature

    November 20, 20264 Views
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025 News Focus 247 Views

    In a stunning development that has sent shockwaves through political and entertainment circles, Attorney General…

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide the daily life news. You find latest trendy news at our portal, from entertainment to economy or politics.

    We're accepting new partnerships right now.

    Email Us: info@im.news

    Facebook X (Twitter) RSS
    Our Picks

    Former US National Security Adviser Jake Sullivan Confronted by Students at MIT

    November 20, 2026

    Robert Pattinson and Suki Waterhouse Redefine Hollywood Power Couples

    November 20, 2026

    Reading Linked to 33% Lower Alzheimer’s Risk, Study Finds

    November 20, 2026
    Most Popular

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025247 Views

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025208 Views

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025165 Views
    © 2026 I'm News. Designed by I'm News.
    • Home
    • Lifestyle
    • Relations
    • Travel & Tourism
    • Technology

    Type above and press Enter to search. Press Esc to cancel.